RBC Capital Reiterates Outperform on Encompass Health, Maintains $83 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Ben Hendrix has reiterated an Outperform rating on Encompass Health (NYSE:EHC) and maintained a price target of $83. This reaffirms the analyst's positive outlook on the company's stock.
February 09, 2024 | 3:57 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital analyst Ben Hendrix has reiterated an Outperform rating on Encompass Health and maintained a price target of $83, indicating a positive outlook on the stock.
The reiteration of an Outperform rating and the maintenance of a $83 price target by a reputable analyst like Ben Hendrix from RBC Capital could instill confidence among investors and potentially lead to a positive short term impact on Encompass Health's stock price. Analyst ratings and price targets are significant indicators for investors, and positive reaffirmations like this can influence market perception and investor sentiment towards the stock.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100